CELG

Celgene Corporation News Headlines

$92
*  
0.64
0.7%
Get CELG Alerts
*Delayed - data as of Aug. 20, 2014  -  Find a broker to begin trading CELG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CELG After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Can Biotech Repeat in 2014?
1/14/2014 5:27:19 AM - Wyatt Investment Research

Cramer's Lightning Round - I Can't Get My Arms Around The New Kodak (1/10/14)
1/12/2014 6:29:00 AM - Seeking Alpha

Cramer's Mad Money - 11 Earnings To Watch In The Week Ahead (1/10/14)
1/12/2014 6:26:00 AM - Seeking Alpha

Celgene, Dendreon Lead Short Interest Trend In Biotechs (BMRN, CELG, DNDN)
1/11/2014 11:46:00 AM - Investopedia

Intercept Pharma Surges on Trial Results - Analyst Blog
1/10/2014 5:46:01 PM - Zacks.com

Getting Ready for Earnings Season with Options - Know Your Options
1/9/2014 3:57:01 AM - Zacks.com

Epizyme Up on Milestone Payments - Analyst Blog
1/8/2014 1:10:01 PM - Zacks.com

Abraxane Label Expansion Lifts Celgene - Analyst Blog
1/8/2014 12:30:01 PM - Zacks.com

Biotech Stock Roundup: Amgen Data Looks Good, CANF Tumbles - Industry Outlook
1/8/2014 10:17:00 AM - Investopedia

Top Funds Like Facebook And Health Care Stocks
1/7/2014 7:59:00 PM - Investor's Business Daily

Closing Update: Stocks Snap Back To 2013 Levels on Bullish Trade Data
1/7/2014 5:09:15 PM - MT Newswires

Healthcare Stocks Ending With Broad Gains; Stereotaxis Rises After Completing Clinical Trial of Surgical Device
1/7/2014 4:53:14 PM - MT Newswires

Sector Update: Healthcare
1/7/2014 4:52:27 PM - MT Newswires

Healthcare Stocks Pacing Market Gains; Community Health Rising on Strong FY14 Revenue Outlook
1/7/2014 3:52:16 PM - MT Newswires

Sector Update: Healthcare
1/7/2014 3:47:47 PM - MT Newswires

Midday Update: Equities Back on the Offensive Following Strong U.S. Trade Data
1/7/2014 1:33:15 PM - MT Newswires

Stocks To Open Higher But Yesterday's Weak ISM Still Weighs
1/7/2014 10:08:39 AM - MT Newswires

Cramer's Mad Money - The Worst S&P 500 Stocks Of 2013 (1/6/14)
1/7/2014 5:58:00 AM - Seeking Alpha

Celgene's Stock Should See New All-Time Highs Due To Strong Pipeline
1/3/2014 2:14:00 PM - Seeking Alpha

Pharmacyclics: As Imbruvica Commercialization Begins, Sell-Off Creates Opportunity
1/3/2014 10:12:00 AM - Seeking Alpha

Acceleron, Celgene Vs. Amgen In The Anemia Drug Race
12/30/2013 1:30:00 AM - Seeking Alpha

Neostem Stands To Benefit From Stem-Cell Deals
12/23/2013 9:20:00 AM - Seeking Alpha

Cramer's Mad Money - Themes That Will Work For 2014 (12/19/13)
12/20/2013 6:23:00 AM - Seeking Alpha

Epizyme: Exciting Science, Exciting Investment Opportunity
12/19/2013 12:41:00 PM - Seeking Alpha

Ziopharm: Finally A Winner In The War On Cancer?
12/15/2013 1:22:00 PM - Seeking Alpha